StockData

Yarrow Bioscience, Inc. (YARW) stock

YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/30102% above fair value
$14.21+0.28 (+2.01%)

Close on Nov 17, 2026Market cap $37.94MP/E –Yield –

Yarrow Bioscience profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Yarrow Bioscience's profit margin for the twelve months ending Jun 30, 2025 was -8097.7%. For fiscal 2025 it was -4646.1%, against -7950.9% the year before. The highest annual figure on record is -634.6% in fiscal 2017.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-4646.1%+3304.8
FY2024Dec 31, 2024-7950.9%−1240.5
FY2023Dec 31, 2023-6710.4%−1844.5
FY2022Dec 31, 2022-4865.8%+3010.5
FY2021Dec 31, 2021-7876.4%−6659.0
FY2020Dec 31, 2020-1217.4%+20267.5
FY2019Dec 31, 2019-21484.9%−19421.9
FY2018Dec 31, 2018-2062.9%−1428.4
FY2017Dec 31, 2017-634.6%+1452.7
FY2016Dec 31, 2016-2087.2%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-3100.0%+11211.9
Q1 FY2026Mar 31, 2026-4168.6%+5878.5
Q2 FY2025Jun 30, 2025-8340.6%−3590.1
Q1 FY2025Mar 31, 2025-4262.9%+2113.7
Q4 FY2024Dec 31, 2024-14311.9%−6169.8
Q3 FY2024Sep 30, 2024-10047.1%−4271.7
Q2 FY2024Jun 30, 2024-4750.5%+2699.9
Q1 FY2024Mar 31, 2024-6376.5%−697.7
Q4 FY2023Dec 31, 2023-8142.1%+157607.9
Q3 FY2023Sep 30, 2023-5775.4%−111.4
Q2 FY2023Jun 30, 2023-7450.4%−723.4
Q1 FY2023Mar 31, 2023-5678.8%−8302.4
Q4 FY2022Dec 31, 2022-165750.0%−161511.9
Q3 FY2022Sep 30, 2022-5664.1%+10339.7
Q2 FY2022Jun 30, 2022-6727.0%+26.9
Q1 FY2022Mar 31, 20222623.6%+11558.4
Q4 FY2021Dec 31, 2021-4238.1%−3697.2
Q3 FY2021Sep 30, 2021-16003.8%−15247.7
Q2 FY2021Jun 30, 2021-6753.9%−5321.3
Q1 FY2021Mar 31, 2021-8934.8%−6635.8
Q4 FY2020Dec 31, 2020-540.9%+15383.6
Q3 FY2020Sep 30, 2020-756.0%+4180.4
Q2 FY2020Jun 30, 2020-1432.6%−1350.3
Q1 FY2020Mar 31, 2020-2299.0%+247.7
Q4 FY2019Dec 31, 2019-15924.4%−15590.1
Q1 FY2019Mar 31, 2019-4936.4%−4037.4
Q2 FY2018Jun 30, 2018-82.3%+1288.1
Q1 FY2018Mar 31, 2018-2546.7%−1327.5
Q4 FY2017Dec 31, 2017-334.3%–
Q3 FY2017Sep 30, 2017-899.0%–
Q2 FY2017Jun 30, 2017-1370.4%–
Q1 FY2017Mar 31, 2017-1219.2%–

More Yarrow Bioscience figures

See a number that looks wrong?